Our perspectives in one place
Type
Topic
Selected filters
Clear
News
See all
IFPMA announces new head of communications
Read moreStatement to the IHR Review Committee on amendments to the International Health Regulations
IFPMA encourages the consistent coordination of the INB and IHR processes to ensure a non-duplicative, fit-for-purpose outcome for all.
Read moreStatement on WTO decision to extend the deadline to consider a waiver of intellectual property rights on COVID-19 therapeutics and diagnostics
IFPMA expresses its disappointment at the decision to consider an extension of a waiver of intellectual property rights on COVID-19 therapeutics and diagnostics taken by Member States at the World Trade Organization (WTO).
Read moreMultilateral framework to nurturing future biodiversity welcomed, despite no acknowledgement yet of the importance for global health security to exempt pathogens
We welcome the adoption at the 15th meeting of the Conference of the Parties to the UN Convention on Biological Diversity (COP15) of a framework that addresses biodiversity loss across the globe.
Read more
IFPMA announces Sunao Manabe as new Vice President
Read moreCall for special pathogen sharing measures to be included in COP15 Digital Sequence Information negotiations
IFPMA statement on behalf of the pharmaceutical industry at the Convention on Biological Diversity (CBD) COP 15 meeting regarding Digital Sequence Information.
Read morePublications
See allGlobal Disease Surveillance and Pathogen Sharing
Following on the heels of COVID-19, global rules on pandemic preparedness and response are being overhauled. Negotiations on a Global Pandemic Accord will kick off in February 2023, and the International Health Regulations (IHR) on responding to global public health emergencies are being revised. Against that background, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) requested that Covington...
Read more
Life-course immunization: Benchmarking main markets and model countries
Immunization is the greatest success story of the twentieth century. Vaccines eliminated most of the childhood diseases that used to cause millions of deaths, making possible a life without disabilities caused by certain communicable diseases like polio for the first time in human history.
Read more
Pathogen sharing and global health security
Responding to the impact of the Nagoya Protocol on Access and Benefit Sharing.
Read more
Expert insights
See all
Vaccines are crucial to lifelong health and future global health security
Read more
Improving child health around the world through immunisation
Read more
Rebuilding momentum on antibiotics research, giving innovators a chance to pull through
Read moreResources
See allAfrica Youth Voices Summit: Activating youthful leadership toward the realization of universal health coverage
Ann-Lise Mikolajczak, Manager, Global Health and Access at IFPMA and Luca Deplano, Associate Manager, Innovation and Access Policy at IFPMA, joined Ryculture Health and Social Innovation’s 2nd Annual YouTH Voices Summit, focused on activating youthful leadership toward the realization of universal health coverage.
Read more
Impact of a waiver of intellectual property rights for COVID-19 therapeutics
As WTO Member States continue to discuss an extension of a waiver of intellectual property (IP) rights on COVID-19 therapeutics, latest evidence and data published today explains what the consequences of such a waiver would have on industry’s ability to fight the COVID-19 pandemic.
Read more
World Patient Safety Day 2022: Making medicines safe and reliable for all
Organized by the Fight the Fakes Alliance during Fight the Fakes Week (5-11 December 2022), this event focused on what medication safety means for patients.
Read more